P1031: LOW-DOSE DOACS IN VERY HIGH-RISK MYELOPROLIFERATIVE NEOPLASMS: LESS BLEEDING BUT MORE ARTERIAL THROMBOTIC EVENTS

por Herbreteau, L., Papageorgiou, L., Le Clech, L., Garcia, G., James, C., Pan-Petesch, B., Couturaud, F., Lippert, E., Gerotziafas, G., Ianotto, J.-C.
Publicado 2022